Inventor · disambiguated record
Karl Peggs
Also filed as: PEGGS KARL
2 granted patents·10 pending applications·4 citations·filing 2016–2024
42Inventor score
Top patents by PatentIndex Score
12 records- 0182US11098121B2“Immune checkpoint intervention” in cancerCANCER RESEARCH TECH LTD·Filed 2016·Granted Aug 24, 2021·4 cites·25 claims
- 0262US2025239324A1Computational methods for clonal neoantigen identificationACHILLES THERAPEUTICS UK LTD·Filed 2024·Application pending·0 cites
- 0358US2023265200A1Anti cd25 fc gamma receptor bispecific antibodies for tumor specific cell depletionCANCER RESEARCH TECH LTD·Filed 2022·Application pending·0 cites
- 0451US2020000903A1Method for Treating CancerCANCER RESEARCH TECH LTD·Filed 2019·Application pending·0 cites
- 0551US2020000904A1Neo-antigen specific t cellsCANCER RESEARCH TECH LTD·Filed 2019·Application pending·0 cites
- 0649US11879014B2Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibodyTUSK THERAPEUTICS LTD·Filed 2018·Granted Jan 23, 2024·0 cites·16 claims
- 0748US2023158073A1Modulation of t cell cytotoxicity and related therapyCANCER RESEARCH TECH LTD·Filed 2021·Application pending·0 cites
- 0845US2019135925A1Anti cd25 fc gamma receptor bispecific antibodies for tumor specific cell depletionCANCER RESEARCH TECH LTD·Filed 2017·Application pending·0 cites
- 0945US2022241333A1Modulation of t cell cytotoxicity and related therapyCANCER RESEARCH TECH LTD·Filed 2020·Application pending·0 cites
- 1042US2018064793A1Method for treating cancerCANCER RESEARCH TECH LTD·Filed 2016·Application pending·0 cites
- 1141US2023226110A1T cell therapyACHILLES THERAPEUTICS UK LTD·Filed 2021·Application pending·0 cites
- 1238US2020283535A1Compounds and methods for tumour-specific cell depletionTUSK THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karl Peggs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →